Download Free Sample Report

COVID-19 has seen the molecular in vitro diagnostics (IVD) industry bring out its best efforts in terms of fast test RT-PCR tests for their systems, point of care solutions, syndromic tests, high throughput systems and surge production on badly needed kits.

The USA market for Global COVID-19 Molecular Diagnostics market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

The China market for Global COVID-19 Molecular Diagnostics  market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

The Europe market for Global COVID-19 Molecular Diagnostics  market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

 

This report contains market size and forecasts of COVID-19 Molecular Diagnostics in Global, including the following market information:

• Global COVID-19 Molecular Diagnostics Market Size 2024-2030, ($ millions)
• The global COVID-19 Molecular Diagnostics market is projected to reach US$ million by 2029.

We surveyed the COVID-19 Molecular Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global COVID-19 Molecular Diagnostics Market, by Type, 2024-2030 ($ millions)
Global COVID-19 Molecular Diagnostics Market Segment Percentages, by Type

• High-throughput Sequencing
• Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR
• Immunological Detection

Global COVID-19 Molecular Diagnostics Market, by Application, 2024-2030 ($ millions)
Global COVID-19 Molecular Diagnostics Market Segment Percentages, by Application

• Hospitals
• Scientific Research
• Biodiagnostics

Global COVID-19 Molecular Diagnostics Market, By Region and Country, 2024-2030 ($ Millions)
Global COVID-19 Molecular Diagnostics Market Segment Percentages, by region and country

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
• The Middle East and Africa (Middle East, Africa)
• South and Central America (Brazil, Argentina, Rest of SCA)

The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:

• Cellex
• Abbott
• Roche
• BioMedomics
• BD
• Henry Schein
• Safecare Bio-Tech
• Thermo Fisher
• Bio-rad
• Agilent
• Ortho Clinical Diagnostics
• Zhejiang Orient Gene Biotech
• Innovita Biological Technology
• Guangzhou Wondfo Biotech
• Guangdong Hecin-Scientific
• Dynamiker Biotechnology (Tianjin)
• ADVAITE
• Mayo Clinic Laboratories
• Chembio Diagnostics
• Mount Sinai Laboratory
• QIAGEN
• Bioer
• Biosynex
• Esco
• Analytik Jena
• Techne
• Da An Gene
• BGI
• Shanghai ZJ Bio-Tech

Outline of Major Chapters:
Chapter 1: Introduces the definition of Ipilimumab, market overview.
Chapter 2: Global COVID-19 Molecular Diagnostics market size in revenue and volume.
Chapter 3: Detailed analysis of COVID-19 Molecular Diagnostics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of COVID-19 Molecular Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global COVID-19 Molecular Diagnostics capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

•